Unlike other previously engineered Ras binders, the engineered Nore1A variants when expressed in A549 lung adenocarcinoma cells, not only inhibited Ras-regulated pro-cancer pathways but also promoted anticancer pathways stimulated by Nore1A. This evidence concerns the gene RASSF5 and cancer.